Elysia 2-1A

Equity
Solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals (equipment / SW / services).
€1,176,100
total amount raised
This campaign has been closed
The increase in capital in which Inventures has participated fits within the larger financing package of Elysia amounting to 1,211,200 EUR together with other Investors.

This financing package was distributed as follows:

- 61,500 EUR were subscribed by the Entrepreneurs

- 500,000 EUR were subscribed by Inventures

- 649,600EUR were subscribed by other investors, including the public fund Meuseinvest



The value of the company prior to this capital increase is presently estimated to have been a maximum of 800,000 EUR. Following this capital increase, the value of the company was 2,011,200 EUR, meaning the estimated value of 800,000 EUR before the increase of capital plus the 1,211,200 EUR now contributed.


This capital increase was done at a subscription price per share of 400.00 EUR.


Elysia and its future investors wanted to allow the general public to participate in this raising of capital by permitting them to refinance part of the capital to which Inventures subscribed during the latest increase of capital. The amount invested by Inventures came to 500,000 EUR. From this amount, a minimum of 35,200 EUR and a maximum of 83,600 EUR will be sold to MyMicroInvest Finance for crowdfunding under the same financial conditions as the initial subscription of capital. The remainder will be kept by Inventures.


The example below shows the case of a transfer of shares for the minimum purchase amount by MyMicroInvest Finance – 35,200 EUR.

The table below shows the percentages of capital held by the Elysia-II Account of MyMicroInvest Finance depending on the results of the issuance of Notes (i.e. a minimum of 35,200 EUR and a maximum of 83,600 EUR) and of the maximum contributed by the other investors (i.e., up to 711,200 EUR).